Provided by Tiger Trade Technology Pte. Ltd.

Petros Pharmaceuticals, Inc.

0.0064
-0.0006-9.29%
Volume:87.03K
Turnover:537.16
Market Cap:269.06K
PE:0.00
High:0.0065
Open:0.0065
Low:0.0055
Close:0.0070
52wk High:2.74
52wk Low:0.0017
Shares:42.37M
Float Shares:42.29M
Volume Ratio:1.29
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2061
EPS(LYR):-83.4693
ROE:-565.29%
ROA:-48.91%
PB:0.08
PE(LYR):0.00

Loading ...

Jan 06, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 27, 2021

Major Issues Report

8-K - Current report
Dec 23, 2021

Major Issues Report

8-K - Current report
Dec 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 01, 2021

Major Issues Report

8-K - Current report
Nov 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 17, 2021

Major Issues Report

8-K - Current report
Nov 16, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 20, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 15, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]